Related Experiment Video
Updated: Jul 18, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Evaluation of a weekend respite program for persons with Alzheimer disease
1School of Nursing, University of British Columbia, Vancouver, Canada. perry@nursing.ubc.ca
Summary
Family caregivers
Area of Science:
- Gerontology
- Dementia Care
- Caregiver Support
Background:
- Family caregivers often face unmet needs.
- Respite programs are underutilized despite these needs.
- Understanding caregiver experiences with respite is crucial.
Purpose of the Study:
- To explore family caregivers' experiences with a pilot respite program.
- To understand factors influencing the use of respite care for individuals with Alzheimer disease (AD) or related dementias.
Main Methods:
- A goal-free evaluation approach was used.
- 18 family caregivers were interviewed about their experience with a pilot weekend respite program.
- Content analysis was performed on interview data.
Main Results:
- Caregiver experiences fell into three categories: self-care, relief, and family member safety/comfort.
- Respite was linked to both caregiver relief and the safety/comfort of the person with dementia.
- Perceived costs and benefits influenced the frequency of program use.
Conclusions:
- Family caregivers' perceptions of respite costs and benefits are key to program utilization.
- Ensuring the safety and comfort of the care recipient is vital for caregiver respite.
- Further research is needed to optimize respite program accessibility and effectiveness.
Related Concept Videos
01:19Restorative Care
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
01:25Continuing Care
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
01:29Documentation in Long-Term and Home Healthcare Setting
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...